Technology Overview
Our innovative, single cell-based monoclonal antibody (SMAB) platform, can efficiently develop monoclonal antibodies from a variety of host animals, especially rabbits.
Compared with other commercial monoclonal antibody development platforms in the market, SMAB offers significant advantages:
SMab: Single cell-based, Speedy platform delivers Superior mAb for customers.
SMabTM: The CURE to your Antibody Needs!